A Study of Ketamine in Patients With Treatment-resistant Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

August 6, 2012

Primary Completion Date

September 12, 2013

Study Completion Date

September 12, 2013

Conditions
Major Depressive Disorder
Interventions
DRUG

Placebo

Form= intravenous infusion, route= intravenous (IV) use. IV infusions of placebo 2 times weekly or IV infusions of placebo 3 times weekly.

DRUG

Ketamine

Type= exact number, unit= mg/kg, number= 0.5, form= intravenous infusion, route= intravenous (IV) use. IV infusions of ketamine 0.50 mg/kg, 2 times weekly or IV infusions of ketamine 0.50 mg/kg, 3 times weekly.

Trial Locations (13)

Unknown

Birmingham

Little Rock

Centennial

Hartford

New Haven

Atlanta

Rockville

Marlton

New York

Allentown

Charleston

Dallas

Salt Lake City

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT01627782 - A Study of Ketamine in Patients With Treatment-resistant Depression | Biotech Hunter | Biotech Hunter